Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zai Lab Ltd

21.90
-1.2500-5.40%
Post-market: 21.60-0.3000-1.37%17:20 EST
Volume:1.01M
Turnover:21.97M
Market Cap:2.44B
PE:-10.77
High:22.20
Open:22.16
Low:21.52
Close:23.15
52wk High:44.34
52wk Low:21.52
Shares:111.27M
Float Shares:109.37M
Volume Ratio:0.84
T/O Rate:0.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0329
EPS(LYR):-2.5984
ROE:-28.97%
ROA:-13.29%
PB:3.21
PE(LYR):-8.43

Loading ...

Stock Track | Zai Lab Plummets 5.05% Pre-Market Amid Broader Decline in Hong Kong's Innovative Drug Sector

Stock Track
·
Nov 07

Hong Kong Stock Connect Innovative Drug Sector Declines in Afternoon Session, Zai Lab Plunges 10%, 520880 Drops 2% Below 10-Day Moving Average, Intraday Premium Surges

Deep News
·
Nov 07

Zai Lab (09688) Reports 14% YoY Revenue Growth in Q3, Totaling $116.1 Million

Stock News
·
Nov 06

Zai Lab Q3 Loss Narrows, Revenue Rises; 2025 Revenue Outlook Revised

MT Newswires Live
·
Nov 06

Stock Track | Zai Lab Plunges 6.45% in Pre-market as Q3 Earnings Miss Estimates

Stock Track
·
Nov 06

Earnings Flash (ZLAB) Zai Lab Posts Q3 Revenue $116.1M, vs. FactSet Est of $141.7M

MT Newswires Live
·
Nov 06

Zai Lab Q3 EPADS $(0.33) Misses $(0.05) Estimate, Sales $116.095M Miss $136.703M Estimate

Benzinga
·
Nov 06

Zai Lab (09688) Provides Update on Amgen's Bemarituzumab Phase 1b/3 FORTITUDE-102 Clinical Trial

Stock News
·
Nov 05

Zai Lab (NasdaqGM:ZLAB): Evaluating Valuation Following Promising Trial Results and Phase 3 Progress

Simply Wall St.
·
Nov 02

JPMorgan Increases Stake in Zai Lab (09688) by Approximately 611,105 Shares at HK$20.56 per Share

Stock News
·
Oct 31

Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading

MT Newswires Live
·
Oct 30

Cantor Fitzgerald Remains a Buy on Zai Lab (ZLAB)

TIPRANKS
·
Oct 27

UBS Initiates “Buy” Rating on Zai Lab (09688) with Clear Catalysts Ahead but Undervalued

Stock News
·
Oct 27

Asian Equities Traded in the US as American Depositary Receipts End Week Higher in Friday Trading

MT Newswires Live
·
Oct 24

Zai Lab Says Potential Lung Cancer Treatment Shows High Response Rate in Updated Phase 1 Data

MT Newswires Live
·
Oct 24

Zai Lab Ltd Enhances Governance with New Committee Charter

TIPRANKS
·
Oct 23

Leerink Partners Sticks to Their Buy Rating for Zai Lab (ZLAB)

TIPRANKS
·
Oct 22

Press Release: Zai Lab to Announce Third Quarter 2025 Financial Results and Recent Corporate Updates on November 6, 2025

Dow Jones
·
Oct 15

Zai Lab falls -6.9%

TIPRANKS
·
Oct 15

Zai Lab Ltd (09688) Grants Stock Options and Restricted Stock Units

Stock News
·
Oct 02